Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours

Carcinogenesis

Volumn 25, Issue 3, 2004, Pages 299-307

  Bignold, Leon P ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CORTICOTROPIN; DNA; DNA POLYMERASE; NUCLEOTIDE;

CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CELL CULTURE; CELL CYCLE S PHASE; CELL GROWTH; CELL NUCLEUS; CELL STRUCTURE; CYTOPLASM; DNA REPLICATION; DNA SEQUENCE; DNA SYNTHESIS; ENZYME DEFECT; ENZYME SYNTHESIS; FRAMESHIFT MUTATION; GENE LOCUS; GENE MUTATION; GENETIC STABILITY; HORMONE SYNTHESIS; HUMAN; HUMAN GENOME; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MISMATCH REPAIR; MUTAGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETINOBLASTOMA; REVIEW; SKIN DEFECT; TUMOR CELL; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DNA REPLICATION; DNA-DIRECTED DNA POLYMERASE; HUMANS; MUTATION; NEOPLASMS;

EID: 1542504597     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh013     Document Type: Review

References (121)

1. Kennaway,E.L. and Hieger,I. (1930) Carcinogenic substances and their fluorescence spectra. Br. Med. J., i, 1044-1046.
2. Burdette,W.J. (1955) The significance of mutation in relation to the origin of tumours: A review. Cancer Res., 15, 201-226.
3. Koller,P.C. (1957) The genetic component of cancer. In Raven R.W. (ed.) Cancer, vol. 1. Butterworth & Co., London, pp. 335-403.
4. Berenblum,I. and Shubik,P. (1949) An experimental study of the initiating stage of carcinogenesis and a re-examination of the somatic cell mutation theory of cancer. Br. J. Cancer, 3, 109-118.
5. Willis,R.A. (1948) Pathology of Tumours. Butterworths, London.
6. Badger,G.M. (1954) Chemical constitution and carcinogenic activity. Adv. Cancer Res., 2, 73-127.
7. Süss,R., Kizel,V. and Scriber,J.D. (1973) Cancer Experiments and Concepts. Springer-Verlag, New York.
8. Berenblum,I. (1958) The study of tumours in animals. In Florey,H.W. (ed.) General Pathology, 2nd Edn. Lloyd-Luke, London, pp. 513-549.
9. Haddow,A. (1973) On the biological alkylating agents. Perspect. Biol. Med., 16, 503-524.
10. Davies,M.J. (2003) Singlet oxygen-mediated damage to proteins and its consequences. Biochem. Biophys. Res. Commun., 305, 761-770.
11. Dipple,A. (1995) DNA adducts of chemical carcinogens. Carcinogenesis, 16, 437-441.
12. Alexander,P. (1954) The reactions of carcinogens with macromolecules. Adv. Cancer Res., 2, 1-72.
13. Heidelberger,C. (1970) Chemical carcinogenesis, chemotherapy: cancer's continuing core challenges-G.H.A. Clowes Memorial Lecture. Cancer Res., 30, 1549-1569.
14. Ketterer,B. (1980) Interactions between carcinogens and proteins. Br. Med. Bull., 36, 71-78.
15. Miller,J.A. (1970) Carcinogenesis by chemicals: An overview-G.H.A. Clowes memorial lecture. Cancer Res., 30, 559-576.
16. Legator,M.S. and Flamm,W.G. (1973) Environmental mutagenesis and repair. Annu. Rev. Biochem., 42, 683-708.
17. Farber,E. (1973) Carcinogenesis-cellular evolution as a unifying thread. Presidential address. Cancer Res., 33, 2537-2550.
18. Cleaver,J.E. (1968) Defective repair replication of DNA in xeroderma pigmentosum. Nature, 218, 652-656.
19. Craddock,V.M. (1971) Liver carcinomas induced in rats by single administration of dimethylnitrosamine after partial hepatectomy. J. Natl Cancer Inst. USA, 47, 899-907.
20. Curtiss,C.C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51 (suppl.), 5023s-5044s.
21. Kemminki,K., Dipple,A., Shuker,D.E.G., Kadlubar,F.F., Segerbäck,D. and Bartsch,H. (eds) (1994) DNA adducts: Identification and biological significance. IARC Scientific Publications No. 125, IARC, Lyon.
22. Kaufmann,W.K. (1989) Pathways of human cell post-replication repair. Carcinogenesis, 10, 1-11.
23. Lawley,P.D. (1994) From fluorescence spectra to mutational spectra, a historical overview of DNA-reactive compounds. IARC Scientific Publications No. 125, IARC, Lyon, pp. 3-22.
24. Seo,K.Y., Jelinsky,S.A. and Loechler,E.L. (2000) Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. Mutat. Res., 463, 215-246.
25. Pages,V. and Fuchs,R.P. (2003) Uncoupling of leading- and lagging-strand DNA replication during lesion bypass in vivo. Science, 300, 1300-1303.
26. Pages,V. and Fuchs,R.P. (2002) How DNA lesions are turned into mutations within cells? Oncogene, 21, 8957-8966.
27. Nestmann,E.R., Bryant,D.W. and Carr,C.J. (1996) Toxicological significance of DNA adducts: Summary of discussions with an expert panel. Regul. Toxicol. Pharmacol., 24, 9-18.
28. Loechler,E.L. (1996) The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems. Carcinogenesis, 17, 895-902.
29. Singer,B. and Eissigman,J.M. (1991) Site-specific mutagenesis: Retrospective and prospective. Carcinogenesis, 12, 949-955.
30. Lockhart-Mummery,J.P. (1934) The Origin of Cancer. J. & A. Churchill, London.
31. Greene,H.S. (1957) Heterotransplantation of tumors. Ann. N. Y. Acad. Sci., 69, 818-829.
32. Fidler,I.J. (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res., 38, 2651-2660.
33. Heppner,G.H. and Miller,F.R. (1998) The cellular basis of tumor progression. Int. Rev. Cytol., 177, 1-56.
34. Busch,H. (1990) The final common pathway of cancer. Cancer Res., 50, 4830-4838.
35. Sandberg,A.A. and Hossfeld D.K. (1970) Chromosomal abnormalities in human neoplasia. Annu. Rev. Med., 21, 379-408.
36. Ohno,S. (1971) Genetic implication of karyological instability of malignant somatic cells. Physiol. Rev., 51, 496-526.
37. Nowell,P.C. (1976) The clonal evolution of tumor cell populations. Science, 194, 23-28.
38. Loeb,L.A. and Kunkel,T.A. (1982) Fidelity of DNA synthesis. Annu. Rev. Biochem., 51, 429-457.
39. Cheng,K.C. and Loeb,L.A. (1993) Genomic instability and tumor progression: Mechanistic considerations. Adv. Cancer Res., 60, 121-156.
40. Coleman,W.B. and Tsongalis,G.J. (1995) Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin. Chem., 41, 644-657.
41. Minnick,D.T. and Kunkel,T.A. (1996) DNA synthesis, errors, mutators and cancer. Cancer Surv., 28, 3-20.
42. Cheng,K.C. and Loeb,L.A. (1997) Genomic stability and instability: A working paradigm. Curr. Top. Microbiol. Immunol., 221, 5-18.
43. Pihan,G.A. and Doxsey,S.J. (1999) The mitotic machinery as a source of genetic instability in cancer. Semin. Cancer Biol., 9, 289-302.
44. Kunkel,T.A. and Bebenek,K. (2000) DNA replication fidelity. Annu. Rev. Biochem., 69, 497-529.
45. Cahill,D.P., Lengauer,C., Yu,J. et al. (1998) Mutations of mitotic checkpoint genes in human cancers. Nature, 392, 300-303.
46. Miyagawa,K. (1998) Genetic instability and cancer. Int. J. Haematol., 67, 3-14.
47. Holloway,S.L., Poruthu,J. and Scata,K. (1999) Chromosome segregation and cancer. Exp. Cell Res., 253, 308-314.
48. Jones,P.A. and Laird,P.W. (1999) Cancer epigenetics comes of age. Nature Genet., 21, 163-167.
49. Hahn,W.C. (2003) Role of telomeres and telomerase in the pathogenesis of human cancer. J. Clin. Oncol., 21, 2034-2043.
50. Loeb,L.A., Springgate,C.F. and Battula,N. (1974) Errors in DNA replication as a basis of malignant changes. Cancer Res., 34, 2311-2321.
51. Loeb,L.A. (2001) A mutator phenotype in cancer. Cancer Res., 61, 3230-3239.
52. Loeb,K.R. and Loeb,L.A. (2000) Significance of multiple mutations in cancer. Carcinogenesis, 21, 379-385.
53. Jackson,A.L. and Loeb,L.A. (2001) The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res., 477, 7-21.
54. Stoler,D.L., Chen,N., Basik,M., Kahlenberg,M.S., Rodriguez-Bigas,M.A., Petrelli,N.J. and Anderson,G.R. (1999) The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl Acad. Sci. USA, 96, 15121-15126.
55. Larson,P.S., de las Morenas,A., Bennett,S.R., Cupples,L.A. and Rosenberg,C.L. (2002). Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am. J. Pathol., 161, 283-290.
56. Hittelman,W.N. (2001) Genetic instability in epithelial tissues at risk of cancer. Ann. N. Y. Acad. Sci., 952, 1-12.
57. Bignold,L.P. (2002) The mutator phenotype/clonal selection hypothesis can provide a basis for the complex and variable morphological and behavioural features of solid tumour malignancies. Cell. Mol. Life Sci., 59, 950-958.
58. Stefanini,M., Lagomarsini,P., Berardesca,E., Borroni,G., Rabbiosi,G. and Nuzzo,F. (1988) Normal sensitivity to mutagens, spontaneous chromosome breakage and mutation frequency in nevoid basal cell carcinoma syndrome. Arch. Dermatol. Res., 280 (suppl.), S19-23.
59. D'adda,T., Pizzi,S., Azzoni,C., Bottarelli,L., Crafa,P., Pasquali,C., Davoli,C., Corleto,V.D., Fave,G.D. and Bordi,C. (2002) Different patterns of 11q allelic losses in digestive endocrine tumors. Hum. Pathol., 33, 322-329.
60. Wittenkeller,J.L., Storer,B., Bittner,G. and Schiller,J.H. (1997) Comparison of spontaneous and induced mutation rates in an immortalized human bronchial epithelial cell line and its tumorigenic derivative. Oncology, 54, 335-341.
61. Sager,R. (1988) Mutation rates and mutational spectra in tumorigenic cell lines. Cancer Surv., 7, 325-333.
62. Kendal,W.S. and Frost,P. (1986) Metastatic potential and spontaneous mutation rates: Studies with two murine cell lines and their recently induced metastatic variants. Cancer Res., 46, 6131-6135.
63. Yamashina,K. and Heppner,G.H. (1985) Correlation of frequency of induced mutation and metastasic potential in tumor cell lines from a single mouse mammary tumor. Cancer Res., 45, 4015-4019.
64. Boyer,J.C., Thomas,D.C., Maher,V.M., McCormick,J.J. and Kunkel,T.A. (1993) Fidelity of DNA replication by extracts of normal and malignantly transformed human cells. Cancer Res., 53, 3270-3275.
65. Speyer,J.F. (1965) Mutagenic DNA polymerase. Biochem. Biophys. Res. Commun., 21, 6-8.
66. Nelson,R.L. and Mason,H.S. (1972) An explicit hypothesis for chemical carcinogenesis. J. Theor. Biol., 37, 197-200.
67. Bignold,L.P. (2003) Initiation of genetic instability and tumour formation: A review and hypothesis of a nongenotoxic mechanism. Cell. Mol. Life Sci., 60, 1107-1117.
68. Alberts,B., Bray,D., Lewis,J., Raff,M., Roberts,K. and Walter,P. (eds) (2002) Molecular Biology of the Cell, 4th Edn. Garland Publishing Inc., New York.
69. Carter,R.L. (ed) (1984) Precancerous States. Oxford University Press, Oxford.
70. IARC (1990) Monographs on the Evaluation of Carcinogenic Risks to Humans. Chromium, Nickel and Welding, Vol. 49. IARC Scientific Publications, IARC, Lyon.
71. IARC (1992) Cadmium in the Human Environment: Toxicity and Carcinogenicity, Vol. 118. IARC Scientific Publications, IARC, Lyon.
72. IARC (1990) Monographs on the Evaluation of Carcinogenic Risks to Humans. Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry, Vol. 58. IARC Scientific Publications, IARC, Lyon.
73. Costa,M., Zoroddu,M.A., Suk,W.A., Thompson,C. and Rossman,T. (eds) (2002) Molecular mechanisms of metal toxicity and carcinogenicity. Environ. Health Perspect. Supplements, 110 (suppl. 5).
74. Jennette,K.W. (1981) The role of metals in carcinogenesis: biochemistry and metabolism. Environ. Health Perspect., 40, 233-252.
75. Sunderman,F.W. (1984) Recent advances in metal carcinogenesis. Ann. Clin. Lab. Sci., 14, 93-122.
76. Sky-Peck,H.H. (1986) Trace metals and neoplasia. Clin. Physiol. Biochem., 4, 99-111.
77. Coogan,T.P., Latta,D.M., Snow,E.T. and Costa,M. (1989) Toxicity and carcinogenicity of nickel compounds. Crit. Rev. Toxicol., 19, 341-384. [Erratum published in: Crit. Rev. Toxicol., 20, 135].
78. Snow,E.T. (1992) Metal carcinogenesis: Mechanistic implications. Pharmacol. Ther., 53, 31-65.
79. Klein,C.B., Snow,E.T. and Frenkel,K. (1998) Molecular mechanisms in metal carcinogenesis: Role of oxidative stress. In Aruoma,O.I. and Halliwell,B. (eds) Molecular Biology of Free Radicals in Human Diseases. OICA International, London, pp. 79-137.
80. Hartwig,A. (1998) Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol. Lett., 102-103, 235-239.
81. Hartwig,A. (2001) Zinc finger proteins as potential targets for toxic metal ions: Differential effects on structure and function. Antioxid. Redox. Signal., 3, 625-634.
82. Sirover,M.A. and Loeb,L.A. (1977) On the fidelity of DNA replication. Effect of metal activators during synthesis with avian myeloblastosis virus DNA polymerase. J. Biol. Chem., 252, 3605-3610.
83. Loeb,L.A., Sirover,M.A., Weymouth,L.A., Dube,D.K., Seal,G., Agarwal,S.S. and Katz,E. (1977) Infidelity of DNA synthesis as related to mutagenesis and carcinogenesis. J. Toxicol. Environ. Health., 2, 1297-1304.
84. Snow,E.T. (1994) Effects of chromium on DNA replication in vitro. Environ. Health Perspect. Suppl., 102 (suppl. 3), 41-4.
85. Chin,Y.E., Snow,E.T. and Christie,N.T. (1994) The stimulatory effect of nickel chloride on DNA replication in human HeLa cells and Escherichia coli. Carcinogenesis, 15, 1013-1016.
86. Pelletier,H., Sawaya,M.R., Wolfle,W., Wilson,S.H. and Kraut,J.A. (1996) Structural basis for metal ion mutagenicity and nucleotide selectivity in human DNA polymerase beta. Biochemistry, 35, 12762-12777.
87. Jin,Y.H., Clark,A.B., Slebos,R.J., Al-Refai,H., Taylor,J.A., Kunkel,T.A., Resnick,M.A. and Gordenin,D.A. (2003) Cadmium is a mutagen that acts by inhibiting mismatch repair. Nature Genet., 34, 326-329.
88. McMurray,C.T. and Tainer,J.A. (2003) Cancer, cadmium and genome integrity. Nature Genet., 34, 239-241.
89. Chan,Y.J. and Becker,F.F. (1979) Decreased fidelity of DNA polymerase activity during N-2-fluorenylacetamide hepatocarcinogenesis. Proc. Natl Acad. Sci. USA, 76, 814-818.
90. Becker,F.F. (1981) Presidential address. Recent concepts of initiation and promotion in carcinogenesis. Am. J. Pathol., 105, 3-9.
91. Brucker,A., Loeb,L.A. and Thielmann,H.W. (1990) DNA polymerase alpha-primase complexes from carcinogen-treated Chinese hamster ovary cells. Cancer Res., 50, 6894-6901.
92. Knudson,A.G. (1996) Hereditary cancer: Two hits revisited. J. Cancer Res. Clin. Oncol., 122, 135-140.
93. Knudson,A.G. (2000) Chasing the cancer demon. Annu. Rev. Genet., 34, 1-19.
94. Knudson,A.G. (2001) Two genetic hits (more or less) to cancer. Nature Rev. Cancer, 1, 157-162.
95. Knudson,A.G. (2002) Cancer genetics. Am. J. Med. Genet., 111, 96-102.
96. Nordling,C.O. (1953) A new theory of the cancer-inducing mechanism. Br. J. Cancer, 7, 68-72.
97. Armitage,P. (1985) Multistage models of carcinogenesis. Environ. Health Perspect., 63, 195-201.
98. Vogelstein,B. and Kinzler,K.W. (1993) The multistep nature of cancer. Trends Genet., 9, 138-141.
99. Kinzler,K.W. and Vogelstein,B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
100. Fiala,S. (1968) The cancer cell as a stem cell unable to differentiate. Neoplasma, 15, 607-622.
101. Pierce,G.B. (1977) Relationship between differentiation and carcinogenesis. J. Toxicol. Environ. Health, 2, 1335-1342.
102. Sell,S. (1993) Cellular origin of cancer: Dedifferentiation or stem cell maturation arrest? Environ. Health Perspect., 101 (suppl. 5), 15-26.
103. Green,S. (1992) Nuclear receptors and chemical carcinogenesis. Trends Pharmacol. Sci., 13, 251-255.
104. Yeldandi,A.V., Rao,M.S. and Reddy,J.K. (2000) Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res., 448, 159-177.
105. Trosko,J.E. and Chang,C.C. (2001) Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. Mutat Res., 480-481, 219-229.
106. Cox,P.M. and Goding,C.R. (1991) Transcription and cancer. Br. J. Cancer, 63, 651-662.
107. Clemens,M.J. and Bommer,U.A. (1999) Translational control: the cancer connection. Int. J. Biochem. Cell Biol., 31, 1-23.
108. Counts,J.L. and Goodman,J.I. (1994) Hypomethylation of DNA: an epigenetic mechanism involved in tumor promotion. Mol. Carcinogen., 11, 185-188.
109. Tycko,B. (2000) Epigenetic gene silencing in cancer. J. Clin. Invest., 105, 401-407.
110. Jones,P.A. and Laird,P.W. (1999) Cancer epigenetics comes of age. Nature Genet. 21, 163-167.
111. Baylin,S.B. and Herman,J.G. (2000) DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet., 16, 168-174.
112. Ehrlich,M. (2002) DNA methylation in cancer: Too much, but also too little. Oncogene, 21, 5400-5413.
113. Lutz,W.K. (1990) Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis. Mutat. Res., 238, 287-295.
114. Pratt,I.S. and Barron,T. (2003) Regulatory recognition of indirect genotoxicity mechanisms in the European Union. Toxicol. Lett., 140-141, 53-62.
115. Lau,S.S., Yoon,H.S, Patel,S.K., Everitt,J.I., Walker,C.L. and Monks,T.J. (2001) Mutagenicity and carcinogenicity of biological reactive intermediates derived from a 'non-genotoxic' carcinogen. Adv. Exp. Med. Biol., 500, 83-92.
116. Davidson,J.F., Guo,H.H. and Loeb,L.A. (2002) Endogenous mutagenesis and cancer. Mutat. Res., 509, 17-21.
117. Kornberg,A. and Tate,T.A. (1992) DNA Replication, 2nd Edn. W. H. Freeman and Co., New York, pp. 197-198.
118. Bebenek,K. and Kunkel,T.A. (1995) Analyzing fidelity of DNA polymerases. Methods Enzymol., 262, 217-232.
119. Nais,A.H. and Fox,M. (1971) Synchronization of mammalian cells with respect to the mitotic cycle. Cell Tissue Kinet., 4, 375-398.
120. Mueller,G.C., Kensler,T.W. and Kajiwara,K. (1978) Mechanisms of DNA and chromatin replication: Possible targets for cocarcinogenesis. In Slaga,T.G., Sivak,A. and Boutwell,R.K. Carcinogenesis, Vol 2, Mechanisms of Tumour Promotion. Raven Press, New York, pp. 79-90.
121. Boyer,J.C., Bebenek,K. and Kunkel,T.A. (1996) Analyzing the fidelity of reverse transcription and transcription. Methods Enzymol., 275, 523-537.